Mode
Text Size
Log in / Sign up

NIV with total face mask managed acute respiratory failure in two patients with Madelung's disease and COVID-19 pneumonia

NIV with total face mask managed acute respiratory failure in two patients with Madelung's disease…
Photo by Testalize.me / Unsplash
Key Takeaway
Consider NIV with total face mask for acute respiratory failure in Madelung's disease patients.

This case series reports on the use of non-invasive ventilation using a total face mask in a population of patients with Madelung's disease. The sample size was two individuals who presented with acute respiratory failure, COVID-19 pneumonia, or obstructive sleep apnea. The primary outcome of interest was the management of acute respiratory failure, which was successfully managed in both cases. No specific adverse event rates or p-values were reported for the primary outcomes. However, bilateral pneumothoraxes were noted as adverse events in the safety profile. The study setting and follow-up duration were not reported. The authors note that the small sample size and observational nature of the data limit the ability to draw definitive conclusions about efficacy or safety across a wider population. Despite these limitations, the findings suggest that a proactive NIV-first approach is a viable and potentially life-saving strategy for this specific clinical scenario. Clinicians should interpret these results with caution given the lack of a control group and the very limited number of participants.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Madelung’s disease (Launois-Bensaude syndrome) presents a critical challenge when managing acute respiratory failure (ARF) due to the high risk of difficult airway and failed intubation posed by symmetric cervical lipomatosis. This case series investigates the feasibility of non-invasive ventilation (NIV) as a primary strategy for ARF in these high-risk patients. We present two cases of severe ARF triggered by COVID-19 pneumonia in patients with Madelung’s disease. Both patients were successfully managed with NIV using a total face mask, which avoided the need for hazardous endotracheal intubation. Key challenges included managing bilateral pneumothoraxes as a complication of NIV in one patient, and identifying and treating severe obstructive sleep apnea (OSA), a prevalent comorbidity as a crucial factor for successful weaning in the other. Our findings, integrated with a review of existing literature, demonstrate that a proactive NIV-first approach is a viable and potentially life-saving strategy in this population. This report provides a practical management framework, emphasizing careful interface selection, vigilance for complications, and systematic screening for underlying OSA to guide clinicians in optimizing outcomes for these complex patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.